MiR-106a-5p targets PFKFB3 and improves sepsis through regulating macrophage pyroptosis and inflammatory response
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Yixin Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China; School of Pharmaceutical Sciences, Guangzhou…. Hauptthemen laut MEDLINE: Phosphofructokinase-2, Sepsis, MicroRNAs, Pyroptosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
The enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 (PFKFB3) is a critical regulator of glycolysis and plays a key role in modulating the inflammatory response, thereby contributing to the development of inflammatory diseases such as sepsis. Despite its importance, the development of strategies to target PFKFB3 in the context of sepsis remains challenging. In this study, we employed a miRNA-based approach to decrease PFKFB3 expression. Through multiple meta-analyses, we observed a downregulation of miR-106a-5p expression and an upregulation of PFKFB3 expression in clinical sepsis samples. These changes were also confirmed in blood monocytes from patients with early sepsis and from a mouse model of lipopolysaccharide (LPS)-induced sepsis. Overexpression of miR-106a-5p significantly decreased the LPS-induced increase in glycolytic capacity, inflammatory response, and pyroptosis in macrophages. Mechanistically, we identified PFKFB3 as a direct target protein of miR-106a-5p and demonstrated its essential role in LPS-induced pyroptosis and inflammatory response in macrophages. Furthermore, treatment with agomir-miR-106a-5p conferred a protective effect in an LPS mouse model of sepsis, but this effect was attenuated in myeloid-specific Pfkfb3 KO mice. These findings indicate that miR-106a-5p inhibits macrophage pyroptosis and inflammatory response in sepsis by regulating PFKFB3-mediated glucose metabolism, representing a potential therapeutic option for the treatment of sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China; School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China.
- Department of Emergency, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
- School of Public Health, UNT Health Science Center, Fort Worth, Texas, USA.
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
- School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
- School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China. Electronic address: yixu@gzhmu.edu.cn.
Zitieren
APA
Chen, Y., Zhang, P., Han, F., Zhou, Y., Wei, J., Wang, C., Song, M., Lin, S., Xu, Y., & Chen, X. (2024). MiR-106a-5p targets PFKFB3 and improves sepsis through regulating macrophage pyroptosis and inflammatory response. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107334
Vancouver
Chen Y, Zhang P, Han F, Zhou Y, Wei J, Wang C, et al. MiR-106a-5p targets PFKFB3 and improves sepsis through regulating macrophage pyroptosis and inflammatory response. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107334
BibTeX
@article{Chen2024,
author = {Chen, Yixin and Zhang, Ping and Han, Fangwei and Zhou, Yanying and Wei, Juexian and Wang, Cailing and Song, Mingchuan and Lin, Shaopeng and Xu, Yiming and Chen, Xiaohui},
title = {MiR-106a-5p targets PFKFB3 and improves sepsis through regulating macrophage pyroptosis and inflammatory response},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107334}
}
EUVIMED